Novo Nordisk
NVO
#25
Rank
NZ$705.42 B
Marketcap
$160.39
Share price
-0.38%
Change (1 day)
-23.46%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Novo Nordisk (NVO) - Cash on Hand

Cash on Hand as of December 2024 : NZ$6.51 Billion

According to Novo Nordisk's latest financial reports the company has NZ$6.51 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Novo Nordisk - Cash on Hand chart (from 1996 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31NZ$7.07 B32.4%
2022-12-31NZ$5.34 B37.2%
2021-12-31NZ$3.89 B33.36%
2020-12-31NZ$2.92 B-15.17%
2019-12-31NZ$3.44 B-3.55%
2018-12-31NZ$3.57 B-16.53%
2017-12-31NZ$4.27 B1.14%
2016-12-31NZ$4.23 B-3.45%
2015-12-31NZ$4.38 B32.17%
2014-12-31NZ$3.31 B1.71%
2013-12-31NZ$3.25 B-6.09%
2012-12-31NZ$3.47 B-11.14%
2011-12-31NZ$3.90 B5.22%
2010-12-31NZ$3.71 B9.15%
2009-12-31NZ$3.40 B3.22%
2008-12-31NZ$3.29 B74.68%
2007-12-31NZ$1.88 B46.91%
2006-12-31NZ$1.28 B10.48%
2005-12-31NZ$1.16 B14.21%
2004-12-31NZ$1.01 B26.27%
2003-12-31NZ$0.80 B73.64%
2002-12-31NZ$0.46 B-54.69%
2001-12-31NZ$1.02 B155.15%
2000-12-31NZ$0.40 B18.28%
1999-12-31NZ$0.33 B61.07%
1998-12-31NZ$0.21 B-21.93%
1997-12-31NZ$0.27 B49.61%
1996-12-31NZ$0.18 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NZ$17.67 B 171.11%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$6.07 B-6.75%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$19.28 B 195.82%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$14.65 B 124.72%๐Ÿ‡ซ๐Ÿ‡ท France